On October 14, 2026 Adagene Inc. (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, reported that Adagene’s Chief Executive Officer and President of R&D, Peter Luo, Ph.D., will participate in a fireside chat at the H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference being held virtually on October 15, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 4th Annual Immune Cell Engager Virtual Conference
Format: Fireside chat
Date: October 15, 2026
Time: 1:30 – 2:00 p.m. ET

A webcast of the fireside chat will be accessible in the Investors section of the Company’s website at View Source for at least 30 days following the conference.

(Press release, Adagene, OCT 14, 2026, View Source [SID1234673475])